BASIS AND RESULTS OF CHEMOTHERAPEUTIC TREATMENT OF GLIOMAS.CRAFTS DC; WILSON CB.1977; BULL. CANCER; FR.; DA. 1977; VOL. 64; NO 1; PP. 101-114; ABS. FR.; BIBL. 3 P.Article

INTRACAROTID BCNU (NSC-409962): A TOXICITY STUDY IN SIX RHESUS MONKEYSCRAFTS DC; LEVIN VA; NIELSEN S et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 5; PP. 541-545; BIBL. 9 REF.Article

CRITERIA FOR EVALUATING PATIENTS UNDERGOING CHEMOTHERAPY FOR MALIGNANT BRAIN TUMORS.LEVIN VA; CRAFTS DC; NORMAN DM et al.1977; J. NEUROSURG.; U.S.A.; DA. 1977; VOL. 47; NO 3; PP. 329-335; BIBL. 5 REF.Article

HYDROLYTIC ENZYMES IN MENINGIOMAL SUBTYPESRAMSEY RB; FREDERICKS M; CRAFTS DC et al.1980; ACTA NEUROPATHOL.; DEU; DA. 1980; VOL. 49; NO 1; PP. 63-65; BIBL. 13 REF.Article

COMPUTERIZED TOMOGRAPHIC AND PATHOLOGIC STUDIES OF THE UNTREATED, QUIESCENT, AND RECURRENT GLIOBLASTOMA MULTIFORMEBURGER PC; DUBOIS PJ; SCHOLD SC JR et al.1983; JOURNAL OF NEUROSURGERY; ISSN 0022-3085; USA; DA. 1983; VOL. 58; NO 2; PP. 159-169; BIBL. 38 REF.Article

LONG-TERM SURVIVAL OF PATIENTS TREATED WITH BCNU FOR BRAIN TUMORS.CALOGERO J; CRAFTS DC; WILSON CB et al.1975; J. NEUROSURG.; U.S.A.; DA. 1975; VOL. 43; NO 2; PP. 191-196; BIBL. 9 REF.Article

BCNU (NSC-409962) AND PROCARBAZINE (NSC-77213) TREATMENT FOR MALIGNANT BRAIN TUMORSLEVIN VA; CRAFTS DC; WILSON CB et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 243-249; BIBL. 11 REF.Article